Background: Velocardiofacial syndrome (VCFS) is one of the most common multiple anomaly syndromes in humans. Pharyngeal hypotonia, one of the most common findings in VCFS, contributes to hypernasal speech, which occurs in approximately 75% of individuals with VCFS.
Results:
The thickness of the SPC muscle was significantly less in patients with VCFS (2.03 mm) than in patients without VCFS (2.85 mm). The SPC muscle contained a significantly greater proportion of type 1 fibers in patients with VCFS (27.7%) than in adults without VCFS (17.9%), and the diameter of the type 1 fibers was significantly smaller in patients with VCFS (21.6 µm) than in adults without VCFS (26.6 
µm).
Conclusions: Differences in the thickness and histologic and histochemical properties of the SPC muscle found in patients with VCFS compared with individuals without VCFS may offer insight into the cause of pharyngeal hypotonia and hypernasal speech seen in these patients. Surg. 2003; 5:503-510 V ELOCARDIOFACIAL syndrome (VCFS) is one of the most common multiple anomaly syndromes in humans. Velocardiofacial syndrome, which has an autosomal dominant inheritance, is a complex disorder with significant phenotypic variability and variable penetrance. The syndrome has been reported to have more than 180 clinical features, none of which occurs with 100% frequency. One of the most recognizable features of VCFS is the development of hypernasal speech, which occurs in approximately 75% of individuals with VCFS. 1, 2 Pharyngeal hypotonia, one of the most common findings in VCFS, contributes to the development of hypernasal speech. However, the etiology of this hypotonia has not been elucidated. An inherent abnormality in one or more of the muscles responsible for closure of the velopharyngeal valve, an abnormality in the central nervous system, or a combination of both might contribute to the hypotonia. Decreased thickness of the posterior pharyngeal wall has been implicated. 3 Closure of the velopharyngeal valve is complex and involves posterosuperior movement of the soft palate (velum), medial movement of the lateral pharyngeal walls, and, in some individuals, anterior movement of the posterior pharyngeal wall. 4, 5 The superior pharyngeal constrictor (SPC) muscle is largely responsible for movement of the lateral and posterior pharyngeal walls. 6 An abnormality in this muscle can adversely affect velopharyngeal function, resulting in hypotonia and hypernasal speech. The SPC muscle arises from the medial pterygoid plate and hamulus. The fibers then curve posteriorly to insert into the median raphe of the pharynx. The muscle extends from the pharyngeal tubercle of the skull superiorly to approximately the level of the third cer-vical vertebra inferiorly. Motor innervation to the SPC muscle is derived from the pharyngeal plexus (vagus and glossopharyngeal nerves). Golding-Kushner 3 demonstrated a decrease in the thickness of the posterior pharyngeal wall on plain radiographs in patients with VCFS. However, further characterization of the SPC muscle in humans has received little attention. The purpose of this study is to evaluate the thickness, histology, and histochemistry of the SPC muscle in patients with VCFS to determine whether a muscle irregularity exists that might contribute to the hypotonia seen in these patients.
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METHODS
MAGNETIC RESONANCE IMAGING
The thickness of the SPC muscle in 26 patients with VCFS (18 male and 8 female; age range, 3-29 years) and 26 patients without VCFS (18 male and 8 female; age range, 3-27 years) was determined using T1-and T2-weighted cervical spine and brain magnetic resonance images (MRIs). Patients without VCFS did not have a primary myopathy. Using computer software (eFilm 1.5 Medical Imaging System; eFilm Medical Inc, Milwaukee, Wis), measurements were taken in the midsagittal plane at the following 3 levels for each patient: the level of the first cervical vertebra, the midpoint of the second cervical vertebra, and the inferior aspect of the second cervical vertebra (Figure 1) . The average of the 3 measurements was taken as the thickness of the muscle.
MUSCLE SPECIMENS
A biopsy specimen of the SPC muscle at the midline of the posterior pharyngeal wall was obtained during routine superior pharyngeal flap surgery in 9 children (3 female and 6 male; age range, 4-12 years) with VCFS. All patients provided informed consent to undergo biopsies, which were approved by the Institutional Review Board at the State University of New York Upstate Medical University, New York. Biopsy specimens were also obtained from 3 adult cadavers (all male; age range, 80-86 years) within 24 hours post mortem before embalming. The biopsy specimens were oriented for serial transverse sectioning, mounted on slices of cork in OTC compound (optimal temperature cutting compound) (Tissue Tek; Miles Laboratories, Naperville, Ill), and frozen in liquid methyl-butane chilled with liquid nitrogen. The specimens were stored at −70°C until sectioning, at which time they were cut into 5-µm sections in a cryostat at −20°C.
General histologic analysis was performed after staining the specimens with modified Gomori trichrome, described as follows. The specimens were placed in hematoxylin at room temperature for 5 minutes, rinsed in distilled water, stained in modified Gomori trichrome at room temperature for 10 minutes, rinsed in 0.2% acetic acid, dehydrated with alcohol, cleared with xylene, and mounted. After mounting, the sections were examined using an optical microscope magnified ϫ40. Oxidative activity was demonstrated by staining the specimens with reduced nicotinamide adenine dinucleotide (NADH), described as follows. The specimens were incubated for 30 minutes in a solution containing NADH, nitro blue tetrazolium, and trizma base-hydrochloric acid buffer at 37°C. They were then rinsed in distilled water, 30% acetone, 60% acetone, 30% acetone again, and distilled water again, dehydrated with alcohol, cleared with xylene, and mounted. After mounting, the sections were examined using an optical microscope magnified at ϫ40.
Enzyme-histochemical analysis was performed after staining the specimens for demonstration of myofibrillar adenosine triphosphatase (ATPase) activity, described as follows. For each patient, some sections were preincubated in calcium chloride-sodium barbital buffer at pH 9.4 for 15 minutes at room temperature, and other sections were preincubated in sodium acetate-acetic acid buffer at pH 4.3 for 5 minutes at room temperature. All stained sections were then incubated for 10 minutes at 37°C in a solution with pH 9.4 containing 0.1M sodium barbital, 0.18M calcium chloride, distilled water, and adenosine triphosphate. The sections were then rinsed in calcium chloride, placed in cobalt chloride for 3 minutes, rinsed in distilled water, placed in 1% ammonium sulfide for 3 minutes, rinsed in distilled water again, dehydrated in alcohol, cleared with xylene, and mounted. After mounting, sections were examined using an optical microscope magnified ϫ40. Individual muscle fibers were identified and differentiated based on their staining intensity for myofibrillar ATPase under different pH conditions. Two major fiber types (types 1 and 2) can be distinguished in human muscles. Type 1 fibers, which have a large amount of oxidative enzymes, are lightly stained at pH 9.4 and darkly stained at pH 4.3. Type 2 fibers, which have a large amount of ATPase, are darkly stained at pH 9.4 and lightly stained at pH 4.3 ( Figure 2 and Figure 3 ). Percent distribution of type 1 vs type 2 fibers was determined. Finally, measurements of muscle fiber diameter were performed using an optical microscope magnified ϫ40 with a micrometer scale contained in one eyepiece. For each patient or cadaver, 64 to 113 muscle fibers were counted.
STATISTICAL ANALYSIS
Muscle thickness data (MRI) were submitted to a 3-factor, mixed-model analysis of variance (ANOVA), crossing location of measurement (first cervical vertebra, midpoint of the second cervical vertebra, and the inferior aspect of the second cervical vertebra) with sex (male and female) and conditions (VCFS and without VCFS). Given no significant interaction terms involving location of measurement, the 3 measurements were averaged to create a single muscle thickness out- , where light-stained muscle fibers correspond to type 2 and dark-stained muscle fibers to type 1, and pH 9.4 (B), where light-stained muscle fibers correspond to type 1 and dark-stained muscle fibers to type 2 (original magnification ϫ20).
come variable for subsequent analyses. Pearson correlation coefficients were used to quantify the relationship between age and average muscle thickness. Type 1 and type 2 average muscle fiber diameters were submitted to a 2-factor, mixed-model ANOVA, crossing fiber type (type 1 and type 2) with condition (VCFS and without VCFS). Given a significant condition by fiber type interaction term, subsequent 1-way analyses compared type 1 fiber diameters in VCFS patients with type 1 fiber diameters in adult cadavers without VCFS and type 2 fiber diameters in VCFS patients with type 2 fiber diameters in adult cadavers without VCFS. Furthermore, the SDs of the muscle fiber diameters were submitted to a similar ANOVA that crossed fiber type (type 1 and type 2) with condition (VCFS and without VCFS). However, no interaction terms were significant and therefore no additional statistical comparisons were conducted. Percent distribution of type 1 fiber data was analyzed with a 1-way ANOVA comparing patients with VCFS with patients without VCFS. Table 1 gives the average thickness of the SPC muscle in patients with and without VCFS, respectively. The overall average muscle thickness was 2.03 mm (SD, 0.49 mm; range, 1.0-3.0 mm) in patients with VCFS and 2.85 mm (SD, 0.30 mm; range, 2.0-3.3 mm) in patients without VCFS. This difference in muscle thickness is statistically significant (PϽ.001). The analysis revealed a significant linear trend contrast (PϽ.003), indicating that the muscle was thicker superiorly (at the level of the first cervical vertebra) and thinner inferiorly (at the inferior aspect of the second cervical vertebra), but this trend was similar between patients with and without VCFS (Figure 4) . Muscle thickness was positively correlated with age in patients with (PϽ.001) and without (P=.02) VCFS. No difference in muscle thickness was noted between males and females in patients with or without VCFS ( Figure 5 ).
RESULTS
MAGNETIC RESONANCE IMAGING
MUSCLE SPECIMENS
Considerable variability in the diameter and shape of the SPC muscle fibers was noted in all VCFS patients and all adult cadavers without VCFS. The fibers had a rounded rather than polygonal configuration and were relatively loosely packed. Compared with adult cadavers without VCFS, VCFS patients had a greater amount of endomysial space between muscle fibers, and the fibers were more loosely packed. Neither adults without VCFS nor VCFS patients demonstrated any peculiar morphologic features, such as ragged red fibers, central nuclei, fiber splitting, nemaline rods, hyaline fibers, or degenerating fibers. In both VCFS patients and adult cadavers without VCFS, type 1 and 2 muscle fibers showed fairly intense staining for NADH such that it was often difficult to distinguish between the 2 fiber types. In general, type 1 fibers stained slightly more intensely Table 2 gives the average muscle fiber diameter and distribution of fiber types in patients with and without VCFS, respectively. The overall average frequency of type 1 fibers was 27.7% (SD, 2.01%; range, 23.9%-31.3%) in VCFS patients and 17.9% (SD, 2.15%; range, 15.9%-20.2%) in adult cadavers without VCFS (Figure 6 ). Conversely, the overall average frequency of type 2 fibers was 72.3% (SD, 1.99%; range, 68.8%-76.1%) in VCFS patients and 82.1% (SD, 2.16%; range, 79.8%-84.1%) in adult (Figure 7) . The 2-factor ANOVA revealed a significant fiber type by condition interaction (PϽ.001) term, indicating that VCFS patients and adult cadavers without VCFS differ in type 1 vs type 2 fiber diameter. Subsequent analysis revealed that the difference in the average diameter of type 1 muscle fibers between VCFS patients and adult cadavers without VCFS was statistically significant (PϽ.001). In patients with VCFS, type 1 fibers were significantly smaller than type 2 fibers (21.6 vs 26.4 µm, respectively). There was no difference in the average diameter between type 1 and type 2 fibers in adult cadavers without VCFS (26.6 and 26.7 µm, respectively). The average type 2 fiber diameter in VCFS patients was similar to the average type 2 fiber diameter in adult cadavers without VCFS (26.4 and 26.7 µm, respectively). Because age and sex were inherent confounders in this study, namely, all VCFS patients were children and all cadavers without VCFS were male adults, no conclusions could be drawn regarding the relationship of age and sex on muscle fiber diameter and distribution of muscle fiber type. Unfortunately, these confounders were necessary due to the limited availability of adult cadavers and the unavailability of child cadavers.
COMMENT
This study analyzes the thickness, histology, and histochemistry of the SPC muscle in patients with VCFS. The significant findings include the following: the decreased thickness of the SPC muscle compared with ageand sex-matched controls; the abundance of endomysial space between muscle fibers in VCFS patients; the increased proportion of type 1 muscle fibers in VCFS patients compared with adults without VCFS; and the smaller diameter of the type 1 muscle fibers in VCFS patients compared with adults without VCFS. These results may be significant in elucidating the etiology of the velopharyngeal hypotonia and subsequent hypernasality frequently seen in patients with VCFS. Velopharyngeal competence, which is largely dependent on adequate function of the soft palate muscles and the SPC muscle, is critical in the development of normal speech. Therefore, a deficiency or an irregularity in any of these muscles might contribute to velopharyngeal hypotonia with subsequent incompetence and hypernasality.
Although no specific abnormalities in SPC muscle fiber morphologic features were present in either VCFS patients or adults without VCFS, VCFS patients exhibited significantly more endomysial space between muscle fibers, resulting in exceedingly loosely packed muscle fibers compared with adults without VCFS. This histologic finding and the atrophy of the type 1 muscle fibers may correspond to the significantly decreased SPC muscle thickness in VCFS patients seen on MRIs.
It is well known that the fiber composition of a muscle strongly influences its functional properties. A high proportion of type 1 fibers typically indicates slow contraction with high resistance to fatigue, whereas a high proportion of type 2 fibers typically indicates fast contraction with low resistance to fatigue. 7 In this study, the SPC muscle was found to contain a much higher proportion of type 2 muscle fibers than type 1 fibers in patients with VCFS and adult cadavers without VCFS. This finding suggests that the SPC muscle possesses fast contraction properties with large, high threshold motor units not well outfitted for finely graded movements. The lit- Figure 4 . Average thickness of the superior pharyngeal constrictor muscle measured on magnetic resonance image with respect to location. C1 represents the level of the first cervical vertebra, mid-C2 represents the midpoint of the second cervical vertebra, and low-C2 represents the inferior aspect of the second cervical vertebra. The difference in the muscle thickness between patients with velocardiofacial syndrome (VCFS) and patients without VCFS is statistically significant (PϽ.001). erature contains a paucity of information regarding the histology and histochemistry of the soft palate muscles and the SPC muscle in humans. Leese and Hopwood 8 found that the mean percentage of type 1 muscle fibers for the pharyngeal constrictor was 32.5% and that the fiber diameter was approximately 30 µm, but they did not specify which pharyngeal constrictor muscle was examined. They also found that there was little difference in fiber type distribution or fiber diameter with respect to age or sex. Stal and Lindman 9 characterized the muscles of the soft palate in 5 healthy adults and found that the palatopharyngeus and uvula contained some of the highest proportions of type 2 fibers ever reported for human muscles (86.2% and 87.2%, respectively), whereas type 1 fibers predominated in the levator and tensor veli palatini muscles (74.9% and 57.0%, respectively). Moon and colleagues 10 determined that the levator veli palatini muscle in 12 healthy adults contained an average of 59.8% type 1 muscle fibers. Lindman and colleagues 11 compared the levator veli palatini muscle in 5 healthy adults with 8 infants with cleft palate. They discovered that infants with cleft palate had a smaller mean fiber diameter, a larger variability in fiber size and form, and a higher proportion of type 2 fibers.
In this study, patients with VCFS were found to have a significantly higher proportion of type 1 muscle fibers than adults without VCFS. Previous studies [12] [13] [14] report relatively stable fiber-type distributions across ages ranging from young adulthood to 100 years. Thus, this differ- Average muscle fiber-type diameter. The difference in the diameter between type 1 fibers and type 2 fibers in patients with velocardiofacial syndrome (VCFS) is statistically significant (PϽ.001). The difference in the diameter of type 1 fibers between patients with VCFS and adult cadavers without VCFS is statistically significant (PϽ.001). There is no statistically significant difference in the diameter between type 1 fibers and type 2 fibers in adult cadavers without VCFS. There is no statistically significant difference in the diameter of type 2 muscle fibers between patients with VCFS and adult cadavers without VCFS. ence in fiber-type distribution is not likely related to phenotypic modification of the SPC muscle due to shifting functional demands during growth and maturation. One possibility is that this difference is a consequence of altered functional activity of the SPC muscle as a result of pharyngeal hypotonia, since it is well known that modifications in muscle activity may cause changes in the fiber type and other characteristics. 15, 16 On the other hand, an intrinsic irregularity in the muscle may be responsible for the altered fiber-type distribution. Velocardiofacial syndrome is caused by a microdeletion of chromosome 22q11. 2, 17 A novel clathrin heavy chain gene, which is not identical to the ubiquitously expressed clathrin heavy chain gene, has been isolated from this area of microdeletion. 18 This novel clathrin heavy chain gene has its maximal level of expression in skeletal muscle. More research has suggested that TBX1, also isolated from this area of microdeletion, is a major candidate gene in the development of the VCFS phenotype. 19 The differences found in this study might be direct or downstream effects due to haploinsufficiency of the clathrin and/or TBX1 genes, an avenue for future research (Bernice E. Morrow, PhD, oral communication, May 2002).
In this study, the type 1 muscle fibers in patients with VCFS had a significantly smaller diameter than the type 1 muscle fibers in adults without VCFS. The type 1 fibers in VCFS patients were also smaller than the type 2 fibers in VCFS patients, which were essentially the same size as both the type 1 and type 2 fibers in adults without VCFS. Lindman and colleagues 11 found that the diameter of the muscle fibers of levator veli palatini muscle in infants with cleft palate was significantly smaller than in adults without cleft palate. They concluded that the early developmental stage, rather than a cleft-associated abnormality, was responsible for this finding. They cited Tomoda and colleagues, 20 who found differences in muscle fiber diameter between infant and adult levator veli palatini muscle samples. The VCFS patients in this study were older and more developed than infants, so the smaller diameter of the type 1 fibers in these patients was not necessarily due to an early developmental stage. Furthermore, the diameter of the type 2 fibers in VCFS patients was equivalent to the diameter of the type 2 fibers in adults without VCFS. Muscle fiber size is related to stimulation by its motor nerve such that frequent stimulation will increase the size of the muscle fibers it innervates and vice versa. Therefore, one possibility to explain the finding in VCFS patients is a lack of frequent stimulation of the type 1 fibers. On the other hand, an intrinsic abnormality of the type 1 muscle fibers, possibly related to haploinsufficiency of the novel clathrin heavy chain gene and/or the TBX1 gene mentioned in the previous paragraph, might be responsible for the smaller type 1 fiber diameter seen in VCFS patients.
The SPC muscle fibers in this study had phenotypic characteristics that are different than those of limb muscles but similar to those of other facial and soft palate muscles. In limb muscles, type 1 fibers usually stain noticeably darker with NADH than type 2 fibers, because they are oxidative and therefore have more mitochondria. 21 In this study, type 2 fibers generally stained almost as strong or as strong as type 1 fibers. Stal and Lindman 9 and Lindman et al 11 found similar results in soft palate muscle fibers and concluded that this high mitochondrial activity of type 2 fibers indicates a high capacity for aerobic metabolism and a high fatigue resistance, which reflects a high demand for blood supply in velopharyngeal movements. Facial and extraocular muscles have also been found to have a higher oxidative capacity than in limb muscles. [22] [23] [24] Diameter of both type 1 and 2 fibers in human limb muscles generally increases with age to a normal of 40 to 80 µm. 25, 26 In this study, the type 2 muscle fiber diameter was similar between the children with VCFS and adults without VCFS, and the average diameter of the adult type 1 and type 2 muscle fibers was 26.6 and 26.7 µm, respectively. Furthermore, there was great variability in diameter and shape of the SPC muscle compared with limb muscles. This concurs with Stal and Lindman, 9 who found significant individual and intramuscular variability in the diameter and shape of the soft palate muscle fibers. This variability is most likely related to anatomic and functional differences between the velopharyngeal muscles and the limb muscles. For example, muscle fiber growth may not be as necessary under the minimal load conditions in the pharynx. Finally, muscle development in the head and neck may be genetically regulated differently than in limb muscles. 27 The histologic arm of this study is limited by the small size of the VCFS group (9 children) and the restricted control group (3 adult cadavers, all male). The study will be continued and will include a larger group of VCFS patients and an expanded control group consisting of younger cadavers and non-VCFS patients undergoing surgery.
In conclusion, significant differences in the thickness, histology, and histochemistry of the SPC muscle were found in patients with VCFS compared with subjects without VCFS. These differences may offer insight into the cause of pharyngeal hypotonia and hypernasal speech seen in these patients. Furthermore, characterization of the SPC muscle revealed a phenotype different than that of limb muscles but similar to that of other facial and soft palate muscles. These findings most likely parallel differences in muscle development and functional demands. A more detailed study of the fiber-type distribution and fiber diameter using muscle tissue obtained from both adults and children is necessary to clarify the characterization of this muscle and to determine the differences between children with and without VCFS and between children without VCFS and adults without VCFS.
